Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avalon Globocare
(NASDAQ:ALBT)
Intraday
$0.26
-0.045
[-14.75%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.26
-0.045
[-14.75%]
Last update: 8:23AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Avalon Globocare Stock (NASDAQ:ALBT)
Avalon Globocare Stock (NASDAQ: ALBT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 22, 2024
Avalon GloboCare Announces Launch Of U.S. Sales Of KetoAir Breathalyzer At Hack Your Health By KetoCon 2024 Conference
Benzinga Newsdesk
-
Apr 22, 2024, 9:07AM
Thursday, March 28, 2024
Avalon GloboCare shares are trading higher after the company announced the extension of its exclusive distribution agreement with Qi Diagnostics to distribute the KetoAir Breathalyzer Device and related accessories in North America, South America, the United Kingdom and the EU.
Benzinga Newsdesk
-
Mar 28, 2024, 12:05PM
Avalon GloboCare Extends Exclusivity Agreement To Distribute KetoAir Breathalyzer Device And AI-Enabled Software In North America, South America, United Kingdom And European Union
Benzinga Newsdesk
-
Mar 28, 2024, 9:02AM
Wednesday, February 28, 2024
Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Feb 28, 2024, 8:24AM
Thursday, November 02, 2023
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 2, 2023, 8:08AM
Wednesday, October 18, 2023
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 18, 2023, 2:15PM
Avalon GloboCare Partners With Qi Diagnostics To Co-Develop International Multi-Center Clinical Studies For DKAir Breathalyzer Device For The Early Detection Of Diabetic Ketoacidosis
Benzinga Newsdesk
-
Oct 18, 2023, 9:01AM
Wednesday, October 04, 2023
Avalon GloboCare Announces Launch Of KetoAir Mobile application In Apple App Store
Bill Haddad
-
Oct 4, 2023, 9:04AM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Oct 2, 2023, 1:00PM
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 29, 2023, 2:09PM
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 28, 2023, 2:32PM
Wednesday, September 13, 2023
Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company And Proprietary FDA-Registered External Male Catheter Device; Terms Not Disclosed
Benzinga Newsdesk
-
Sep 13, 2023, 9:17AM
Tuesday, September 05, 2023
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Sep 5, 2023, 1:34PM
Avalon GloboCare shares are trading higher after the company announced the USPTO issued a notice of publication for a US patent titled 'QTY Fc Fusion Water Soluble Receptor Proteins'
Benzinga Newsdesk
-
Sep 5, 2023, 1:23PM
Avalon GloboCare Announces Notice Of Publication For Key U.S. Patent Filed Jointly With The Massachusetts Institute Of Technology
Happy Mohamed
-
Sep 5, 2023, 8:18AM
Wednesday, August 30, 2023
EXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosis
Vandana Singh
-
Aug 30, 2023, 8:45AM
EXCLUSIVE: Avalon GloboCare Tells Benzinga 'New Test Method Expected to Generate Revenue in 2023'
Benzinga Newsdesk
-
Aug 30, 2023, 8:45AM
EXCLUSIVE: Avalon GloboCare Tells Benzinga Co Announces Its Subsidiary aboratory Services MSO, LLC Is Now Offering An In-House Laboratory Developed Test ("LDT") To Detect Tuberculosis ("TB") Using A Patient's Sputum Aample
Benzinga Newsdesk
-
Aug 30, 2023, 8:45AM
Monday, August 28, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 28, 2023, 1:54PM
Thursday, August 10, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Aug 10, 2023, 1:43PM
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 9, 2023, 12:27PM
Monday, July 24, 2023
Avalon's Laboratory Services MSO Acquires Texas Lab With Significant Potential Growth; No Financial Terms Disclosed
Happy Mohamed
-
Jul 24, 2023, 9:08AM
Wednesday, July 19, 2023
Avalon GloboCare shares are trading higher after the company announced Laboratory Services MSO signed an exclusive Master Service Agreement with GeneX Laboratory Professional Corp.
Benzinga Newsdesk
-
Jul 19, 2023, 12:09PM
Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity Into 21 States
Happy Mohamed
-
Jul 19, 2023, 9:13AM
Monday, July 10, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Jul 10, 2023, 1:50PM
Avalon GloboCare Provides Update On New Commercial Strategy; Continues To Implement Major Change In Strategy Focused On Acquiring And Operating Accretive Revenue Generating Laboratories And Related Commercialized Products
Happy Mohamed
-
Jul 10, 2023, 9:13AM
Thursday, April 27, 2023
Avalon GloboCare Reports Laboratory Services MSO Revenue Of $14.7M And Net Income Of $6.3M In 2022
Happy Mohamed
-
Apr 27, 2023, 9:17AM
Tuesday, April 11, 2023
Avalon GloboCare Signs Agreement With Qi Diagnostics To Exclusively Distribute KetoAir Breathalyzer Device And AI-Enabled Software In North America, South America, U.K. And European Union
Happy Mohamed
-
Apr 11, 2023, 9:01AM
Friday, March 24, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Mar 24, 2023, 12:05PM
Thursday, March 23, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Mar 23, 2023, 1:11PM
Avalon Globocare Filed Form RW, Withdrawing Registration Statement S-3
Charles Gross
-
Mar 23, 2023, 6:08AM
Monday, March 06, 2023
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Mar 6, 2023, 1:25PM
Avalon GloboCare Corp. shares are trading higher on above-average volume. Not currently seeing company-specific news.
Benzinga Newsdesk
-
Mar 6, 2023, 11:24AM
What's Going On With Kala Pharmaceuticals Shares Today
Aaron Bry
-
Mar 6, 2023, 10:33AM
What's Going On With Avalon GloboCare Shares Today
Aaron Bry
-
Mar 6, 2023, 10:12AM
Nasdaq Rises 50 Points; US Factory Orders Down 1.6% In January
Lisa Levin
-
Mar 6, 2023, 10:04AM
Benzinga Pro's Top 5 Stocks To Watch For Monday, March 6, 2023: JD, GE, CIEN, GHSI, ALBT
Benzinga Newsdesk
-
Mar 6, 2023, 9:10AM
Monday, February 13, 2023
Avalon GloboCare Announces Closing Of Strategic Investment In Laboratory Services MSO, A Leading Clinical Diagnostics And Reference Laboratory Company; Total Consideration For The Transaction Was $21M
Happy Mohamed
-
Feb 13, 2023, 9:11AM
Monday, January 23, 2023
Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar
Chris Katje
-
Jan 23, 2023, 11:14AM
Tuesday, January 17, 2023
Kala Pharmaceuticals, Getty Images And This Bitcoin Stock Top Short Squeeze Leaderboard: 10 Short Squeeze Stocks To Watch
Chris Katje
-
Jan 17, 2023, 11:38AM
Avalon GloboCare Announces Issuance Of Key U.S. Patent For Multiple Novel QTY-Code Modified Cytokine And Chemokine Protein Receptor Molecules
Benzinga Newsdesk
-
Jan 17, 2023, 9:06AM
Tuesday, January 03, 2023
Avalon GloboCare Announces Deployment Of Fusion Gene Map Technology
Bill Haddad
-
Jan 3, 2023, 9:03AM
Thursday, December 29, 2022
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Dec 29, 2022, 1:14PM
Monday, December 12, 2022
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Dec 12, 2022, 1:05PM
Avalon GloboCare Announces A New Proposed Board Composition In Preparation For Acquisition Of Laboratory Services MSO, LLC
Benzinga Newsdesk
-
Dec 12, 2022, 9:02AM
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch